false
0001037868
0001037868
2026-11-20
2026-11-20
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 20, 2026
AMETEK, Inc.
(Exact name of registrant as specified in its charter)
Commission File Number: 1-12981
| Delaware |
|
14-1682544 |
| (State or other jurisdiction of |
|
(I.R.S. Employer |
| incorporation or organization) |
|
Identification No.) |
| |
|
|
| 1100 Cassatt Road Berwyn PA |
|
19312 |
| (Address of principal executive offices) |
|
(Zip Code) |
(610)
647-2121
(Registrant’s telephone number, including
area code)
Not Applicable
(Former name or former address, if changed since
last report.)
Securities registered pursuant to Section
12(b) of the Act:
| Title of each class |
Trading Symbol(s) |
Name of exchange on which registered |
| Common Stock, $0.01 Par Value (voting) |
AME |
New
York Stock Exchange (NYSE) |
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. ¨
Item 1.01. Entry into
a Material Definitive Agreement.
USD Notes
On
November 20, 2026, AMETEK, Inc. (the “Company”) completed the sale of $500,000,000 aggregate principal amount of
the Company’s 5.550% Senior Notes due 2031 (the “USD Notes”).
The
USD Notes bear interest at a rate of 5.550% per year, payable semiannually in arrears on May 20 and November 20 of each year,
beginning on May 20, 2027. The USD Notes will mature on November 20, 2031, unless earlier redeemed or repurchased. The Company
may redeem the USD Notes, in whole or in part, at any time prior to October 20, 2031 at a “make-whole” redemption price
set forth in the First Supplemental Indenture (which redemption price may not be less than the principal amount of the USD Notes to be
redeemed) and at any time on or after October 20, 2031 at 100% of the principal amount, in each case, plus accrued and unpaid interest,
if any, to the date of redemption.
CAD Notes
On
November 20, 2026, the Company completed the sale of C$600,000,000 aggregate principal amount of the Company’s 4.500% Senior
Notes due 2032 (the “CAD Notes”).
The
CAD Notes bear interest at a rate of 4.500% per year, payable semiannually in arrears on May 20 and November 20 of each year,
beginning on May 20, 2027. The CAD Notes will mature on November 20, 2032, unless earlier redeemed or repurchased. The Company
may redeem the CAD Notes, in whole or in part, at any time prior to September 20, 2032 at a “make-whole” redemption price
set forth in the Third Supplemental Indenture (which redemption price may not be less than the principal amount of the CAD Notes to be
redeemed) and at any time on or after September 20, 2032 at 100% of the principal amount, in each case, plus accrued and unpaid interest,
if any, to the date of redemption.
EUR Notes
On
November 20, 2026, the Company completed the sale of €1,500,000,000 aggregate principal amount of the Company’s EUR Notes
as follows: €750,000,000 aggregate principal amount of the Company’s 4.150% Senior Notes due 2030 (the “EUR 2030 Notes”)
and €750,000,000 aggregate principal amount of the Company’s 4.450% Senior Notes due 2034 (the “EUR 2034 Notes”
and, together with the EUR 2030 Notes, the “EUR Notes”).
The
EUR 2030 Notes bear interest at a rate of 4.150% per year, payable annually in arrears on November 20 of each year, beginning on
November 20, 2027. The EUR 2030 Notes will mature on November 20, 2030, unless earlier redeemed or repurchased. The Company
may redeem the EUR 2030 Notes, in whole or in part, at any time prior to October 20, 2030 at a “make-whole” redemption
price set forth in the Second Supplemental Indenture (which redemption price may not be less than the principal amount of the EUR 2030
Notes to be redeemed) and at any time on or after October 20, 2030 at 100% of the principal amount, in each case, plus accrued and
unpaid interest, if any, to the date of redemption.
The
EUR 2034 Notes bear interest at a rate of 4.450% per year, payable annually in arrears on November 20 of each year, beginning on
November 20, 2027. The EUR 2034 Notes will mature on November 20, 2034, unless earlier redeemed or repurchased. The Company
may redeem the EUR 2034 Notes, in whole or in part, at any time prior to August 20, 2034 at a “make-whole” redemption
price set forth in the Second Supplemental Indenture (which redemption price may not be less than the principal amount of the EUR 2034
Notes to be redeemed) and at any time on or after August 20, 2034 at 100% of the principal amount, in each case, plus accrued and
unpaid interest, if any, to the date of redemption.
Indenture
The
USD Notes, CAD Notes and EUR Notes are referred to collectively as the “Notes”. The Notes were issued under and are governed
by an Indenture, dated as of November 10, 2026 (the “Base Indenture”), by and between the Company and U.S. Bank Trust
Company, National Association, as trustee (the “Trustee”), as supplemented and amended by a First Supplemental Indenture,
dated as of November 20, 2026, by and between the Company and the Trustee (the “First Supplemental Indenture”), a Second
Supplemental Indenture, dated as of November 20, 2026, by and between the Company and the Trustee (the “Second Supplemental
Indenture”) and a Third Supplemental Indenture, dated as of November 20, 2026, by and between the Company and the Trustee (the
“Third Supplemental Indenture” and, together with the Second Supplemental Indenture, the First Supplemental Indenture and
the Base Indenture, the “Indenture”).
The
Notes are unsecured and unsubordinated obligations of the Company. The Notes rank equal in right of payment with all of the Company’s
existing and future unsecured and unsubordinated indebtedness and the Notes are effectively subordinated to all indebtedness and other
liabilities, including trade payables, of the Company’s subsidiaries.
Subject
to a number of important qualifications and exceptions, the Indenture, among other things, limits the Company’s ability and the
ability of the Company’s restricted subsidiaries to create liens and to enter into sale and leaseback transactions and limit the
Company’s ability to merge or consolidate with or into other entities or to sell, lease or convey all or substantially all of the
Company’s and its restricted subsidiaries’ assets, taken as a whole.
The
Indenture provides for certain events of default which include (subject in certain cases to grace and cure periods), among others, nonpayment
of principal or interest; breach of covenants or warranties in the Indenture; defaults under or failure to pay certain other indebtedness;
failure to pay certain final judgments; and certain events of bankruptcy, insolvency, reorganization, administration or similar proceedings.
The
foregoing is a brief description of certain terms of the Indenture and, by its nature, is incomplete. It is qualified in its entirety
by the text of the Indenture. The Company is filing the First Supplemental Indenture as Exhibit 4.2, Second Supplemental Indenture
as Exhibit 4.3 and Third Supplemental Indenture as Exhibit 4.4 to this Current Report on Form 8-K, and has filed the Base
Indenture with the Securities and Exchange Commission on November 10, 2026 as Exhibit 4.8 to the Company’s Registration
Statement on Form S-3, all of which are incorporated herein by reference.
Item 8.01. Other Events.
The
legal opinion of Morgan, Lewis & Bockius LLP as to the validity of the Notes is attached as Exhibit 5.1 to this Current
Report on Form 8-K and such opinion contains the consent of Morgan, Lewis & Bockius LLP to the filing of its opinion as
an exhibit to this Current Report on Form 8-K.
Forward-Looking
Statements
Certain
of the statements contained in this Current Report on Form 8-K are “forward-looking statements” within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the
“Securities Exchange Act”). Words such as “aim,” “anticipate,” “believe,” “can,”
“continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,”
“on track,” “opportunity,” “plan,” “possible,” “potential,” “predict,”
“project,” “seek,” “should,” “strive,” “sustain,” “synergy,” “target,”
“will,” “would” and similar expressions are intended to identify forward-looking statements, but the absence of
these words does not mean that a statement is not forward-looking. These statements are based on management’s current expectations
and are subject to uncertainty and changes in circumstances and speak only as of the date hereof. These statements are not guarantees
of future performance and are based on assumptions and estimates that could prove incorrect or could cause actual results to vary materially
from those indicated. A more detailed discussion of the risks and uncertainties that could cause the Company’s actual results to
differ materially from those indicated is included in the “Risk Factors” and “Management’s Discussion and Analysis”
sections in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and elsewhere in that
report and other reports filed by the Company pursuant to the Securities Exchange Act. The Company undertakes no obligation to publicly
update or revise any forward-looking statements, except as required by the federal securities laws.
Item 9.01. Financial
Statements and Exhibits.
(d) Exhibits.
Exhibit Number |
|
Description |
| |
|
| 4.1 |
|
Indenture, dated as of November 10, 2026, between AMETEK, Inc. and U.S. Bank Trust Company, National Association, as trustee (filed as Exhibit 4.8 to the Company’s Registration Statement on Form S-3 filed November 10, 2026, and incorporated by reference herein). |
| 4.2 |
|
First Supplemental Indenture, dated November 20, 2026, by and between AMETEK, Inc. and U.S. Bank Trust Company, National Association (including Form of Senior Note). |
| 4.3 |
|
Second Supplemental Indenture, dated November 20, 2026, by and between AMETEK, Inc. and U.S. Bank Trust Company, National Association (including Form of Senior Note). |
| 4.4 |
|
Third Supplemental Indenture, dated November 20, 2026, by and between AMETEK, Inc. and U.S. Bank Trust Company, National Association (including Form of Senior Note). |
| 5.1 |
|
Opinion of Morgan, Lewis & Bockius LLP. |
| 23.1 |
|
Consent of Morgan, Lewis & Bockius LLP (contained in Exhibit 5.1). |
| 104 |
|
Cover Page Interactive Data File (formatted as Inline XBRL) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
AMETEK, Inc. |
| |
|
|
| November 20, 2026 |
By: |
/s/ ROBERT J. AMODEI |
| |
|
Name: Robert J. Amodei |
| |
|
Title: Senior Vice President – Controller |